search
Back to results

Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance

Primary Purpose

Hypercholesterolemia, Statin-Associated Myopathy

Status
Completed
Phase
Phase 2
Locations
United States
Study Type
Interventional
Intervention
Red Yeast Rice
Pravastatin
Lifestyle modification program
Sponsored by
University of Pennsylvania
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Hypercholesterolemia focused on measuring Statin related myalgia, Hyperlipidemia, Red yeast rice, Cardiovascular Diseases, Nutritional and Metabolic Diseases

Eligibility Criteria

21 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Subject reports stopping at least one statin drug due to complaints of muscle pain or weakness which his/her physician thinks was attributable to the drug.
  • Subject has never taken pravastatin.
  • Subject willing to remain off the dietary supplements CoQ10, L-carnitine, fish oil, policosanol, and guggulipid, garlic, and phytosterols in margarines (e.g. Benecol, Promise activ), milk or cereal products, for one month prior to the trial and for the duration of the trial.

Exclusion Criteria:

  • A history of muscle damage (CK>1000 IU) on statin therapy.
  • A history of generalized chronic pain such as fibromyalgia, or generalized arthritis.
  • Any active cardiac problem including chest pain, angina, heart attack, bypass surgery, angioplasty/stent or unstable angina/acute coronary syndrome within the past 6 months.
  • Taking other lipid lowering drugs including: ezetimibe, gemfibrozil, niacin, fibrates or bile acid sequestrants.
  • Triglyceride level more than 400 mg/dl.
  • Taking weight loss medication including orlistat, sibutramine, diethylpropion, phendimetrazine, phentermine.
  • Taking pain medication or systemic steroids on a chronic basis.

Sites / Locations

  • Chestnut Hill Hospital

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Experimental

Arm Label

Pravastatin

Red yeast Rice

Arm Description

Outcomes

Primary Outcome Measures

Withdrawal of Therapy Due to Muscle Symptoms That Are Either Intolerable and/or Associated With a Creatine Kinase(CK) >500

Secondary Outcome Measures

Change in LDL-Cholesterol Measured at the Beginning and End of the Study

Full Information

First Posted
March 14, 2008
Last Updated
December 9, 2009
Sponsor
University of Pennsylvania
Collaborators
Chestnut Hill Health System
search

1. Study Identification

Unique Protocol Identification Number
NCT00639223
Brief Title
Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance
Official Title
Red Yeast Rice vs. Pravastatin: A Double-Blind Randomized Comparative Study of Myopathic Symptoms
Study Type
Interventional

2. Study Status

Record Verification Date
December 2009
Overall Recruitment Status
Completed
Study Start Date
January 2008 (undefined)
Primary Completion Date
July 2008 (Actual)
Study Completion Date
October 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
University of Pennsylvania
Collaborators
Chestnut Hill Health System

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will examine the effect of red yeast rice extract compared to pravastatin on muscle related complaints in individuals with high cholesterol who have previously been unable to tolerate statin medications due to muscle pain. The study will determine whether red yeast is associated with a lower level of muscle related complaints compared to pravastatin.
Detailed Description
20 million Americans are actively treated with statins at an annual cost of 16 billion dollars. Statins are effective therapeutic agents for reducing LDL cholesterol and have documented effectiveness. However, a significant subset of patients (5-18%), cannot tolerate lipid lowering statin therapy due to intolerable muscle-related symptoms characterized by muscle pain and/or weakness. These symptoms affect quality of life and lead to poor adherence. Patients may seek alternative therapies to manage hypercholesterolemia if they have been intolerant of statin therapy. One commonly used alternative treatment option is the Chinese herb red yeast rice extract. Several small studies performed in China, have suggested this treatment is efficacious and well tolerated. In the U.S. red yeast rice is sold over the counter a dietary supplement. The objective of this study is to critically examine the safety and efficacy of the Chinese herb red yeast rice as an alternative lipid lowering therapy, in a statin intolerant population. This objective will be operationalized by a double-blind randomized trial, comparing the effect of red yeast rice extract, to that of pravastatin on the level of myalgia in subjects with a prior history of statin-induced myalgias. The specific aims include: Determine the relative rates of withdrawal from treatment in subjects receiving red yeast rice compared to pravastatin. Determine if red yeast rice is associated with a lower level of muscle pain (myalgia) symptoms compared to pravastatin as measured by the Brief Pain Inventory, a validated pain questionnaire. Determine if red yeast rice is associated with a lower level of muscle weakness compared to pravastatin as measured by a dynamometry, a validated muscle strength testing method.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypercholesterolemia, Statin-Associated Myopathy
Keywords
Statin related myalgia, Hyperlipidemia, Red yeast rice, Cardiovascular Diseases, Nutritional and Metabolic Diseases

7. Study Design

Primary Purpose
Treatment
Study Phase
Phase 2
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
43 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Pravastatin
Arm Type
Active Comparator
Arm Title
Red yeast Rice
Arm Type
Experimental
Intervention Type
Dietary Supplement
Intervention Name(s)
Red Yeast Rice
Intervention Description
Four 600mg capsules twice daily for 12 weeks
Intervention Type
Drug
Intervention Name(s)
Pravastatin
Other Intervention Name(s)
Pravachol
Intervention Description
One 20mg capsule twice daily for 12 weeks
Intervention Type
Behavioral
Intervention Name(s)
Lifestyle modification program
Intervention Description
Weekly sessions each lasting 3 1/2 hours for 12 weeks
Primary Outcome Measure Information:
Title
Withdrawal of Therapy Due to Muscle Symptoms That Are Either Intolerable and/or Associated With a Creatine Kinase(CK) >500
Time Frame
12 weeks
Secondary Outcome Measure Information:
Title
Change in LDL-Cholesterol Measured at the Beginning and End of the Study
Time Frame
12 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
21 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Subject reports stopping at least one statin drug due to complaints of muscle pain or weakness which his/her physician thinks was attributable to the drug. Subject has never taken pravastatin. Subject willing to remain off the dietary supplements CoQ10, L-carnitine, fish oil, policosanol, and guggulipid, garlic, and phytosterols in margarines (e.g. Benecol, Promise activ), milk or cereal products, for one month prior to the trial and for the duration of the trial. Exclusion Criteria: A history of muscle damage (CK>1000 IU) on statin therapy. A history of generalized chronic pain such as fibromyalgia, or generalized arthritis. Any active cardiac problem including chest pain, angina, heart attack, bypass surgery, angioplasty/stent or unstable angina/acute coronary syndrome within the past 6 months. Taking other lipid lowering drugs including: ezetimibe, gemfibrozil, niacin, fibrates or bile acid sequestrants. Triglyceride level more than 400 mg/dl. Taking weight loss medication including orlistat, sibutramine, diethylpropion, phendimetrazine, phentermine. Taking pain medication or systemic steroids on a chronic basis.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Steven C Halbert, MD
Organizational Affiliation
University of Pennsylvania
Official's Role
Study Director
Facility Information:
Facility Name
Chestnut Hill Hospital
City
Philadelphia
State/Province
Pennsylvania
ZIP/Postal Code
19118
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Safety of Red Yeast Rice for High Cholesterol in Individuals With Statin Intolerance

We'll reach out to this number within 24 hrs